Atom Investors’s Alkermes ALKS Stock Holding History

Atom Investors’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,000	Closed	-$187K	–	241
2021 Q1	$187K	Buy	+10,000	New	+$205K	0.03%	219

Other funds holding ALKS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Atom Investors's ALKS Position: Q1 2026 in Review

Atom Investors sold out of Alkermes (ALKS) in Q1 2026, closing a stake of 65,706 shares — an estimated $1.84M sold.

Atom Investors first reported a position in ALKS in Q1 2020 and held it in 6 quarters. The position peaked at $14.1M in Q4 2020. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

Atom Investors reported no remaining Alkermes position as of Q1 2026 after selling out during the quarter.
Atom Investors sold 65,706 Alkermes shares in Q1 2026, an estimated $1.84M.
Atom Investors first reported a position in Alkermes in Q1 2020 and held it in 6 quarters.
Atom Investors's Alkermes position peaked at $14.1M in Q4 2020.
388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.